Home
About
Overview
Sharing Data
ORCID
Help
History (3)
An open-label trial of risperidone augmentation for refractory anxiety disorders.
Proteomic and phospho-proteomic profile of human platelets in basal, resting state: insights into integrin signaling.
Ultrasonographic evaluation of renal infections.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
An open-label trial of risperidone augmentation for refractory anxiety disorders.
An open-label trial of risperidone augmentation for refractory anxiety disorders. J Clin Psychiatry. 2006 Mar; 67(3):381-5.
View in:
PubMed
subject areas
Adult
Ambulatory Care
Antidepressive Agents
Antipsychotic Agents
Anxiety Disorders
Benzodiazepines
Diagnostic and Statistical Manual of Mental Disorders
Drug Administration Schedule
Drug Resistance
Drug Therapy, Combination
Female
Humans
Male
Panic Disorder
Phobic Disorders
Psychiatric Status Rating Scales
Risperidone
Severity of Illness Index
Treatment Outcome
authors with profiles
Mark Pollack